Since PTPs relevant to insulin resistance are promising antidiabetic targets, the identification of PTPN2 and PTPN6 inhibitors could be an effective strategy for treating or preventing type 2 diabetes. This evidence concerns the gene PTPN6 and Insulin resistance.